Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study

BACKGROUND: Validity is the ability of an instrument to measure what it claims to measure. It means the degree to which the empirical evidence supports the trustworthiness of interpretations based on the calculated scores. The hematological malignancy (HM) specific patient reported outcome measure (...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Al-Obaidi, Magda J., Oblak, Metod, Salek, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506039/
https://www.ncbi.nlm.nih.gov/pubmed/33013368
http://dx.doi.org/10.3389/fphar.2020.01308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506039/
https://www.ncbi.nlm.nih.gov/pubmed/33013368
http://dx.doi.org/10.3389/fphar.2020.01308

Ejemplares similares